Territory Includes: MA, RI, CT, NH, ME
The Medical Science Liaison (MSL) will represent the Company and its dermatology portfolio, initially focusing on an FDA approved novel boron-containing small molecule for the treatment of atopic dermatitis.
As a member of the Medical Affairs field-based team, the MSL will identify and engage with health care providers (HCPs) in dermatology and pediatric dermatology, providing disease state information and responding to unsolicited medical requests for information. Additionally, the MSL will identify interested researchers, and educational opportunities. The MSL will be required to collaborate with commercial colleagues when compliantly tasked. It is expected, that the MSL be solidly versed in the clinical data such that the full range of innovative science and clinical outcomes can be appreciated by the healthcare practitioner, formulary member and/or Payer.